Digitalis purpurea" extract containing cardiac glycosides for the treatment of heart conditions was first described in the English-speaking medical literature by William Withering, in 1785, which is considered the beginning of modern therapeutics. It is used to increase cardiac contractility (it is a positive inotrope) and as an antiarrhythmic agent to control the heart rate, particularly in the irregular (and often fast) atrial fibrillation. Digitalis is hence often prescribed for patients in atrial fibrillation, especially if they have been diagnosed with congestive heart failure. Digoxin was approved for heart failure in 1998 under current regulations by the Food and Drug Administration
What We Do in the Shadows the silly to the satiric may bite, but the anemic pic isn't remotely weird or witty enough for cult immortality." "What We Do in the Shadows" grossed US $2 million in New Zealand and $3.4 million in the US. "What We Do in the Shadows" was released on DVD and Blu-ray on 26 November 2014 by Weltkino Filmverleih. A sequel to the film, which focused on the werewolves depicted in "What We Do in the Shadows", was in development but stopped due to some unresolved production issues. Originally rumoured to be titled "What We Do in the Moonlight", the working